Mebendazole (Compound)

Synonyms:mebendazole, 31431-39-7, Vermox, Pantelmin, Telmin, Mebenvet, Ovitelmin, Vermicidin, Vermirax, Mebenoazole, Bantenol, Mebutar, Lomper, MBDZ, Besantin, Verpanyl, Noverme, Mebendazolum, Methyl (5-benzoyl-1H-benzo[d]imidazol-2-yl)carbamate, 5-Benzoyl-2-benzimidazolecarbamic acid methyl ester, Methyl 5-benzoyl-2-benzimidazolecarbamate, Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester, Methyl 5-benzoyl-2-benzimidazolylcarbamate, R 17,635, methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate, C16H13N3O3, R 17635, Methyl 5-benzoyl benzimidazole-2-carbamate, (5-Benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester, MFCD00057872, Methyl N-(5-benzoyl-1H-benzimidazol-2-yl)carbamate, Zhihuanqing, CCRIS 4479, methyl (5-benzoyl-1H-benzimidazol-2-yl)carbamate, methyl N-(6-benzoyl-1H-1,3-benzodiazol-2-yl)carbamate, NSC 184849, 2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester, Sufil, CHEMBL685, NSC-184849, N-2 (5-Benzoyl-benzimidazole) carbamate de methyle, N-(Benzoyl-5, benzimidazolyl)-2, carbamate de methyle, CHEBI:6704, Mebendazol, DTXSID4040682, Carbamic acid, N-(5-benzoylbenzimidazol-2-yl)-, methyl ester, Versid, Methyl 6-benzoyl-1H-benzimidazol-2-ylcarbamate, 81G6I5V05I, R-17635, 5-Benzoyl-2-benzimidazolecarbamic acid, methyl ester, MMV003152, NSC184849, methyl [5-(phenylcarbonyl)-1H-benzimidazol-2-yl]carbamate, NCGC00016806-01, (5-Benzoyl-1H-benzimidazol-2-yl)carbamic acid methyl ester, Mebex, CAS-31431-39-7, Equivurm Plus, Mebendazol [INN-Spanish], Mebendazolum [INN-Latin], Vermox (TN), DTXCID2020682, Emverm, SMR000036734, HSDB 3232, SR-01000003109, EINECS 250-635-4, Methyl N-(5-benzoyl-2-benzimidazolyl)carbamate, Mebatreat, Mebendazole (JAN/USP/INN), UNII-81G6I5V05I, Equivurmp Plus, N-2 (5-Benzoyl-benzimidazole) carbamate de methyle [French], Mebendazole,(S), N-(Benzoyl-5, benzimidazolyl)-2, carbamate de methyle [French], V95, Prestwick_310, Mebendazole; 4030, Mebendazole [USAN:USP:INN:BAN:JAN], Spectrum_001298, CPD000036734, Prestwick0_000217, Prestwick1_000217, Prestwick2_000217, Prestwick3_000217, Spectrum2_001401, Spectrum3_001439, Spectrum4_000416, Spectrum5_001381, MEBENDAZOLE [INN], MEBENDAZOLE [JAN], MEBENDAZOLE [HSDB], MEBENDAZOLE [USAN], Probes1_000013, Probes2_000149, MEBENDAZOLE [VANDF], Cambridge id 5250893, Methyl [5-(Benzoyl)benzimidazol-2-yl]carbamate, TimTec1_000869, MEBENDAZOLE [MART.], Oprea1_278237, Oprea1_768530, SCHEMBL15860, BSPBio_000233, BSPBio_003178, CBDivE_010559, KBioGR_000712, KBioSS_001778, MEBENDAZOLE [USP-RS], MEBENDAZOLE [WHO-DD], MEBENDAZOLE [WHO-IP], MLS000028491, MLS006011879, BIDD:GT0087, DivK1c_000751, MEBENDAZOLUM [WHO-IP], SPECTRUM1501110, SPBio_001442, SPBio_002154, BPBio1_000257, methyl N-[6-(benzoyl)-1H-benzimidazol-2-yl]carbamate, MEBENDAZOLE [GREEN BOOK], HMS502F13, KBio1_000751, KBio2_001778, KBio2_004346, KBio2_006914, KBio3_002398, MEBENDAZOLE [ORANGE BOOK], Mebendazole for system suitability, NINDS_000751, 2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester (8CI), HMS1536H11, HMS1568L15, HMS1921F03, HMS2090B03, HMS2092B15, HMS2095L15, HMS3259B11, HMS3604N11, HMS3712L15, MEBENDAZOLE [EP MONOGRAPH], MEBENDAZOLE [USP IMPURITY], Pharmakon1600-01501110, MEBENDAZOLE [USP MONOGRAPH], Tox21_110620, BBL008298, BDBM50180753, CCG-39628, NSC757838, s4610, STK093862, AKOS000539066, AKOS015896232, Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester (9CI), Tox21_110620_1, CS-3974, DB00643, NC00639, NSC-757838, IDI1_000751, NCGC00016806-02, NCGC00016806-03, NCGC00016806-04, NCGC00016806-05, NCGC00016806-06, NCGC00016806-07, NCGC00016806-08, NCGC00016806-09, NCGC00016806-10, NCGC00016806-12, NCGC00016806-13, NCGC00021698-03, NCGC00021698-04, NCGC00021698-05, NCGC00021698-06, NCGC00021698-07, AC-12064, AS-12272, HY-17595, SY051142, SBI-0051641.P002, AB00052203, FT-0628179, FT-0628180, M2273, EN300-50844, D00368, D70118, 5-Benzoyl-2-benzimidazolylcarbamicacidmethylester, AB00052203-09, AB00052203_10, Mebendazole, VETRANAL(TM), analytical standard, A820852, AG-205/04588045, Mebendazole, analytical standard, >=98% (HPLC), Methyl (6-benzoyl-1H-benzimidazol-2-yl)carbamate, Q422194, methyl 5-benzoyl-1H-benzo[d]imidazol-2-ylcarbamate, SR-01000003109-2, SR-01000003109-3, W-106901, BRD-K77987382-001-01-7, BRD-K77987382-001-06-6, BRD-K77987382-001-08-2, SR-01000003109-10, methyl N-(5-benzoyl-1H-1,3-benzimidazol-2-yl)carbamate, Z234895185, 5-Benzoyl-1H-benzimidazol-2-yl carbamic acid methyl ester;, Mebendazole, European Pharmacopoeia (EP) Reference Standard, Mebendazole, United States Pharmacopeia (USP) Reference Standard, Mebendazole for system suitability, European Pharmacopoeia (EP) Reference Standard

Pubchem:PUBCHEM:4030

Id:06b67034-4d3d-5d23-bc57-840bc50d6f4e

Description:nan